Provided by Tiger Fintech (Singapore) Pte. Ltd.

WUXI BIO

22.800
-0.300-1.30%
Volume:22.83M
Turnover:523.15M
Market Cap:93.78B
PE:26.00
High:23.400
Open:23.250
Low:22.600
Close:23.100
Loading ...

Wuxi Biologics' Growth Trajectory Stable But Tariff Risks Linger -- Market Talk

Dow Jones
·
24 Apr

HK Movers | Biotech Stocks Rally With Zai Lab up 8%

Tiger Newspress
·
23 Apr

HK Movers|HK Pharma Stocks Shined. Ascletis up 18%; Dualitybio up 8%; Zai Lab, HBM and Remegen Up 6%.

Tiger Newspress
·
22 Apr

HK Movers|HK Pharma Stocks Shined. Zai Lab Up 15%; HBM Up 10%; Remegen Up 9%; Alphamab And Wuxi Bio Up 5%.

Tiger Newspress
·
14 Apr

Shares of WuXi Biologics Set to Open Down 8.2%

THOMSON REUTERS
·
09 Apr

Shares of WuXi Biologics Down 24%

THOMSON REUTERS
·
07 Apr

Individual investors who have a significant stake must be disappointed along with institutions after WuXi Biologics (Cayman) Inc.'s (HKG:2269) market cap dropped by HK$12b

Simply Wall St.
·
04 Apr

Chinese Biotech Stocks Outshine Tech Rally on Robust Earnings

Bloomberg
·
01 Apr

Jefferies Adjusts WuXi Biologics (Cayman)'s Price Target to HK$45 From HK$35, Keeps at Buy

MT Newswires Live
·
31 Mar

Greater China Stocks Close Mixed; Hong Kong Leads Gainers

Dow Jones
·
27 Mar

BRIEF-WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025

Reuters
·
25 Mar

WuXi Biologics' Profit Slides 1.3% in 2024

MT Newswires Live
·
25 Mar

BRIEF-WuXi Biologics Posts FY Revenue Of RMB18,675.4 Mln

Reuters
·
25 Mar

HK Pharma Stocks Shined. Wuxi Apptec And Alphamab Surged 11%, Wuxi Bio Soared 8%, Wuxi XDC Up 7%, Tigermed Up 5%.

Tiger Newspress
·
18 Mar

WuXi Biologics (Cayman) Inc. (HKG:2269) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable

Simply Wall St.
·
16 Mar

Greater China Stocks Close Mixed; Hong Kong Leads Gainers

Dow Jones
·
14 Mar

WuXi Biologics Included in S&P Global Sustainability Yearbook 2025

THOMSON REUTERS
·
11 Mar

WuXi Biologics (Cayman) Inc.'s (HKG:2269) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Simply Wall St.
·
05 Mar

Greater China Stocks Slip; Taiwan Sees Largest Decline

Dow Jones
·
24 Feb

Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$30.59 From HK$19.30, Keeps at Buy

MT Newswires Live
·
20 Feb